IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

LANS PHARMA LLP

LLPIN : AAG-4866|ROC: RoC-MumbaiActive
Last Updated On : 17-08-2024
LLPINAAG-4866
LLP NameLANS PHARMA LLP
Number of Partners3
Number of Designated Partners3
ROC CodeRoC-Mumbai
Date of Incorporation27-05-2016
Registered Address1306 SHUBHAM AVENUE ,BUILDING NO.1921 PANT NAGAR,SHRI GURUDUTT MANDIR MARG ,GHATKOPAR,EAST Mumbai Mumbai Mumbai Maharashtra India 400075
Email ID[email protected]
Total Obligation of Contribution2,00,000
Main division of business activity to be carried out in India24
Description of main divisionMANUFACTURING
Date of last financial year end for Statement of Accounts and Solvency2020-03-31
Date of last financial year end for Annual Return filed31-03-2024
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
01894394LALIT NAROTTAMDAS SHAH27-05-2016
07208689ANKIT LALIT SHAH29-01-2024
05190292NAMIT LALIT SHAH29-01-2024
LANS PHARMA LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Mumbai, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 27-05-2016 and last updated on 17-08-2024. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, LANS PHARMA LLP has a total contribution of INR 2,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is 1306 SHUBHAM AVENUE ,BUILDING NO.1921 PANT NAGAR,SHRI GURUDUTT MANDIR MARG ,GHATKOPAR,EAST Mumbai Mumbai Mumbai Maharashtra India 400075. Correspondence or inquiries may be sent to the official email address, [email protected].
For those interested in further details, below are some frequently asked questions: